neuroendocrine tumor |
Disease ID | 1050 |
---|---|
Disease | neuroendocrine tumor |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:4) C0494165 | liver metastases | 34 C0206754 | neuroendocrine neoplasm | 2 C0153690 | bone metastases | 1 C0001339 | acute pancreatitis | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:4) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121908586 | 17566086 | 5156 | PDGFRA | umls:C0206754 | BeFree | Multiple GISTs and other tumors may be caused by germline PDGFRA gene mutations; the V561D mutation can occur in the germline state and lead to a syndrome that should not be confused with other genetic conditions associated with a predisposition to NETs and other tumors. | 0.000542884 | 2007 | PDGFRA | 4 | 54274869 | T | A |
rs797044481 | NA | 1027 | CDKN1B | umls:C0206754 | CLINVAR | NA | 0.243267234 | NA | CDKN1B;GPR19 | 12 | 12717966 | C | TAA |
rs797044482 | NA | 1027 | CDKN1B | umls:C0206754 | CLINVAR | NA | 0.243267234 | NA | CDKN1B;GPR19 | 12 | 12718118 | - | T |
rs797044483 | NA | 1027 | CDKN1B | umls:C0206754 | CLINVAR | NA | 0.243267234 | NA | CDKN1B;GPR19 | 12 | 12718173 | A | - |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:4) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0206754 | everolimus | D000068338 | - | neuroendocrine tumors | MESH:D018358 | therapeutic | 21306238 | ||
C0206754 | interferon alfacon-1 | C050739 | 118390-30-0 | neuroendocrine tumors | MESH:D018358 | therapeutic | 17331326 | ||
C0206754 | octreotide | D015282 | 83150-76-9 | neuroendocrine tumors | MESH:D018358 | therapeutic | 1322274 | ||
C0206754 | paclitaxel | D017239 | - | neuroendocrine tumors | MESH:D018358 | therapeutic | 11468447 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |